StockData
Skye Bioscience, Inc. logo

Skye Bioscience, Inc. (SKYE) stock

SKYENasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 3/30
$1.03+0.03 (+3.00%)

Close on Nov 18, 2026Market cap $36.48MP/E –Yield –

Skye Bioscience pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Skye Bioscience's pe ratio was 5.5× on Jul 31, 2020.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2020Jul 31, 20205.5×–

More Skye Bioscience figures

See a number that looks wrong?